Literature DB >> 21245194

Wnt signaling in estrogen-induced lactotroph proliferation.

Adam Giles1, Frederic Madec, Sönke Friedrichsen, Karen Featherstone, Tom Chambers, Claire V Harper, Julia Resch, Georg Brabant, Julian R E Davis.   

Abstract

Prolactinomas are the most common type of functioning pituitary adenoma in humans, but the control of lactotroph proliferation remains unclear. Here, using microarray analysis, we show that estrogen treatment increased expression of Wnt4 mRNA in adult Fischer rat pituitary tissue. Dual immunofluorescence analysis revealed that Wnt4 expression was not confined to lactotrophs, but that it was expressed in all anterior pituitary cell types. Estradiol induced proliferation in the somatolactotroph GH3 cell line, in parallel with Wnt4 mRNA and protein induction. A reporter gene assay for TCF- and LEF-dependent transcription revealed that there was no activation of the canonical Wnt pathway in GH3 cells upon stimulation with Wnt-conditioned culture medium or coexpression of constitutively active mutant β-catenin. Expression of β-catenin in both GH3 cells and normal rat anterior pituitary cells was restricted to the cell membrane and was unaltered by treatment with estradiol, with no nuclear β-catenin being detected under any of the conditions tested. We show for the first time that Wnt4 affects non-canonical signaling in the pituitary by inhibiting Ca(2+) oscillations in GH3 cells, although the downstream effects are as yet unknown. In summary, Wnt4 is expressed in the adult pituitary gland, and its expression is increased by estrogen exposure, suggesting that its involvement in adult tissue plasticity is likely to involve β-catenin-independent signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21245194      PMCID: PMC3031368          DOI: 10.1242/jcs.078642

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  50 in total

1.  Homeodomain-mediated beta-catenin-dependent switching events dictate cell-lineage determination.

Authors:  Lorin E Olson; Jessica Tollkuhn; Claudio Scafoglio; Anna Krones; Jie Zhang; Kenneth A Ohgi; Wei Wu; Makoto M Taketo; Rolf Kemler; Rudolf Grosschedl; Dave Rose; Xue Li; Michael G Rosenfeld
Journal:  Cell       Date:  2006-05-05       Impact factor: 41.582

2.  Characterization of adherens junction protein expression and localization in pituitary cell networks.

Authors:  Norbert Chauvet; Taoufik El-Yandouzi; Marie-Noëlle Mathieu; Audrey Schlernitzauer; Evelyne Galibert; Chrystel Lafont; Paul Le Tissier; Iain C Robinson; Patrice Mollard; Nathalie Coutry
Journal:  J Endocrinol       Date:  2009-06-08       Impact factor: 4.286

Review 3.  Fine structural cytology of the adenohypophysis in rat and man.

Authors:  E Horvath; K Kovacs
Journal:  J Electron Microsc Tech       Date:  1988-04

4.  Effects of estradiol on prolactin and growth hormone messenger RNAs in cultured normal and neoplastic (MtT/W15 and GH3) rat pituitary cells.

Authors:  J Y Song; L Jin; R V Lloyd
Journal:  Cancer Res       Date:  1989-03-01       Impact factor: 12.701

5.  Effect of pregnancy on the somatotroph and the prolactin cell of the human adenohypophysis.

Authors:  L G Goluboff; C Ezrin
Journal:  J Clin Endocrinol Metab       Date:  1969-12       Impact factor: 5.958

6.  Frequent nuclear accumulation of beta-catenin in pituitary adenoma.

Authors:  S Semba; S Y Han; H Ikeda; A Horii
Journal:  Cancer       Date:  2001-01-01       Impact factor: 6.860

7.  Inhibition of estrogen-induced pituitary tumor growth and angiogenesis in Fischer 344 rats by the matrix metalloproteinase inhibitor batimastat.

Authors:  Slawomir A Mucha; Gabriela Meleń-Mucha; Andrzej Godlewski; Henryk Stepień
Journal:  Virchows Arch       Date:  2007-01-18       Impact factor: 4.064

Review 8.  Signalling to transcription: store-operated Ca2+ entry and NFAT activation in lymphocytes.

Authors:  Yousang Gwack; Stefan Feske; Sonal Srikanth; Patrick G Hogan; Anjana Rao
Journal:  Cell Calcium       Date:  2007-06-18       Impact factor: 6.817

9.  Isolation and characterization of a novel pituitary tumor apoptosis gene.

Authors:  Adil Bahar; David J Simpson; Steve J Cutty; John E Bicknell; Paul R Hoban; Sarah Holley; Mirna Mourtada-Maarabouni; Gwyn T Williams; Richard N Clayton; William E Farrell
Journal:  Mol Endocrinol       Date:  2004-04-22

Review 10.  Caught up in a Wnt storm: Wnt signaling in cancer.

Authors:  Rachel H Giles; Johan H van Es; Hans Clevers
Journal:  Biochim Biophys Acta       Date:  2003-06-05
View more
  8 in total

1.  Effects of the estrogen receptor antagonist fulvestrant on F344 rat prolactinoma models.

Authors:  Lei Cao; Hua Gao; Songbai Gui; Giwei Bai; Runchun Lu; Fei Wang; Yazhuo Zhang
Journal:  J Neurooncol       Date:  2014-01-10       Impact factor: 4.130

2.  Oral Contraceptive and Menopausal Hormone Therapy Use and Risk of Pituitary Adenoma: Cohort and Case-Control Analyses.

Authors:  David J Cote; John L Kilgallon; Noah L A Nawabi; Hassan Y Dawood; Timothy R Smith; Ursula B Kaiser; Edward R Laws; JoAnn E Manson; Meir J Stampfer
Journal:  J Clin Endocrinol Metab       Date:  2022-03-24       Impact factor: 5.958

3.  GPR50 interacts with TIP60 to modulate glucocorticoid receptor signalling.

Authors:  Jian Li; Laura E Hand; Qing-Jun Meng; Andrew S I Loudon; David A Bechtold
Journal:  PLoS One       Date:  2011-08-17       Impact factor: 3.240

4.  Effects of fulvestrant on biological activity and Wnt expression in rat GH3 cells.

Authors:  Jiwei Bai; Yan Wang; Chuzhong Li; Yazhuo Zhang
Journal:  Neural Regen Res       Date:  2012-02-05       Impact factor: 5.135

5.  Gremlin, a bone morphogenetic protein antagonist, is a crucial angiogenic factor in pituitary adenoma.

Authors:  Kenta Koketsu; Daizo Yoshida; Kyongsong Kim; Yudo Ishii; Shigeyuki Tahara; Akira Teramoto; Akio Morita
Journal:  Int J Endocrinol       Date:  2015-03-05       Impact factor: 3.257

6.  Role of Estrogen Response Element in the Human Prolactin Gene: Transcriptional Response and Timing.

Authors:  Anne V McNamara; Antony D Adamson; Lee S S Dunham; Sabrina Semprini; David G Spiller; Alan S McNeilly; John J Mullins; Julian R E Davis; Michael R H White
Journal:  Mol Endocrinol       Date:  2015-12-21

7.  Case Report: Progression of a Silent Corticotroph Tumor to an Aggressive Secreting Corticotroph Tumor, Treated by Temozolomide. Changes in the Clinic, the Pathology, and the β-Catenin and α-SMA Expression.

Authors:  Gianina Demarchi; Sofía Perrone; Gaela Esper Romero; Cristian De Bonis; Juan Pablo Casasco; Gustavo Sevlever; Silvia Ines Berner; Carolina Cristina
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-19       Impact factor: 6.055

8.  Dynamic Expression of Imprinted Genes in the Developing and Postnatal Pituitary Gland.

Authors:  Valeria Scagliotti; Ruben Costa Fernandes Esse; Thea L Willis; Mark Howard; Isabella Carrus; Emily Lodge; Cynthia L Andoniadou; Marika Charalambous
Journal:  Genes (Basel)       Date:  2021-03-30       Impact factor: 4.096

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.